作者单位：
Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield
[1]
Department of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University
[2]
The Zena and Michael Weiner Cardiovascular Institute, Icahn School of Medicine at Mount Sinai
[3]
Massachusetts General Hospital
[4]
Department of Health Sciences Research, Mayo Clinic, Rochester, MN, former employee at Duke
[5]
AstraZeneca Research and Development
[6]
Stanford Center for Clinical Research (SCCR), Department of Medicine, Stanford University School of
[7]
Duke Clinical Research Institute, Duke University Medical Center
[8]
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School
[9]
Department Hospitalo-Universitaire FIRE, AP-HP, Hopital Bichat, Paris, France
[10]
Canadian VIGOUR Centre, University of Alberta
[11]
Division of Cardiovascular Health and Disease, Heart, Lung and Vascular Institute, University of
[12]
发布时间
2020-04-10
换一批
